AGP Picks
View all

Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

Press releases published on June 1, 2026

NAMPO Show brings US$3.39 million in business prospects for Brazil’s agricultural machinery sector
AFRICANLICIOUS LAUNCHES GLOBAL MARKETPLACE TURNING AFRICAN FOOD, CULTURE AND TALENT INTO OPPORTUNITY
EIN Presswire Announces June Special on Press Release Distribution Packages
Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
Refined Energy Corp. Clarifies Certain Promotional Disclosure
Discovery Completes Acquisition of Kidd Operations
Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines Provides Vormatrigine Program Update
UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
XS.com Conquista o Prêmio de “Melhor Programa de IB” na Wealth Expo Colombia 2026
Orano Increases Ownership in Cigar Lake Mine in Canada
Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones
LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Share this page:

Sign up for:

Africa In The News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.